Noradrenaline Bitartrate 69815-49-2

97%-102%, USP36

Product categories

New Products

Product Details

Product Information

Product name	Noradrenaline Bitartrate
CAS No.	69815-49-2
Molecular Formula	C8H11NO3.C4H6O6.H2O
Molecular Weight	337.28
Molecular Structure
Quality Standard	97.0~102.0%, calculated on the anhydrous basis
Appearance	White to faintly gray, odorless, crystalline powder

COA

ANALYSIS	SPECIFICATION	RESULTS
Appearance	White to faintly gray, odorless, crystalline powder	Conforms
Solubility	Freely soluble in water, slightly soluble in ethanol (96%)	Conforms
Identification
A:	Infrared absorption	Conforms
B:	An intensely green color develops	Conforms
C:	The solution is colorless or has at most a slight pink or slight violet color	Conforms
Specific rotation	Between -10°and -12°	-11.4°
Water	Between 4.5% and 5.8%	5.40%
Residue on ignition	Not more than 0.1%, from 200mg	0.03%
Limit of arterenone	Not more than 0.2	0
Assay	97.0~102.0%, calculated on the anhydrous basis	99.30%
Bacterial endotoxins	Not more than 83.4EU/mg of Noradrenaline base	<83.4 EU/mg
Residual Solvent	Ethanol content: Not more than 5000ppm	28ppm
Conclusion	The product conforms to USP36.

Usage

What is Norepinephrine Bitartrate?

Norepinephrine Bitartrate is and adrenergic receptor, the contraction of blood vessels and boost the role of strong and heart rate caused by reflex, but sitmulate the heart, bronchodilators are less effective, Norepinephrine Bitartrate is mainly used in anti-shock, as a result of anesthesia induced shock, toxic shock, cardiac shock .

Norepinephrine Bitartrate Injection, which is indicated for blood pressure control in certain acute hypotensive states (e.g., pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, septicemia, blood transfusion, and drug reactions) and as an adjunct in the treatment of cardiac arrest and profound hypotension.

*Products under the patent are only for R&D use